Diagnostic tools ,and management strategies for coronary artery disease in patients with end-stage renal disease

Seminars in Nephrology

Volumn 21, Issue 1, 2001, Pages 13-24

  Sorrell, Vincent L ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMLODIPINE; ANTIHYPERTENSIVE AGENT; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; DOBUTAMINE; ERYTHROPOIETIN; GEMFIBROZIL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METOPROLOL; MINOXIDIL; NICOTINIC ACID; VASODILATOR AGENT;

ANEMIA; ARTICLE; COMORBIDITY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; DIALYSIS; HEART CATHETERIZATION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SURVIVAL; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT PLANNING;

EID: 0035137337     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/snep.2001.18371     Document Type: Article

References (75)

1. Survival rates of 2,728 patients with end-stage renal disease
2. Accelerated atherosclerosis in long-term dialysis and renal-transplant patients: Fact or fiction?
3. Analysis of probability as an aid to the clinical diagnosis of coronary artery disease
4. Psycho-physical basis of perceived exertion
5. Prognostic importance of a clinical profile and exercise test in medically treated patients with coronary artery disease
6. Preoperative assessment and perioperative management of cardiac ischemic risk in non-cardiac surgery
7. Special Report
8. Evaluation of cardiovascular risk for renal transplantation in diabetic patients
9. Predictive value of thallium stress testing for coronary and cardiovascular events in uremic diabetic patients before renal transplantation
10. Value of exercise echocardiogram in detecting the severity of coronary artery disease in patients with positive exercise echocardiography
11. Prognostic significance of ST-segment depression during adenosine perfusion imaging
12. Rapidly progressive, massive mitral annulus calcification: Occurrence in a patient with chronic renal failure
13. Exercise cross-sectional echocardiography in ischemic heart disease
14. The physiologic basis of dobutamine as compared with dipyradamole stress interventions in the assessment of critical coronary stenosis
15. High-dose dipyridamole echocardiography test in effort angina pectoris
16. Exercise echocardiography: A clinically practical addition in the evaluation of coronary artery disease
17. Accuracy and limitations of exercise echocardiography in a routine clinical setting
18. Usefulness of dobutamine stress echocardiography in detecting coronary artery disease in end-stage renal disease
19. Echocardiographic detection of coronary artery disease during dobutamine infusion
20. Pharmacologic methods instead of exercise for the assessment of coronary artery disease
21. Evaluation using dobutamine stress echocardiography in patients with insulin dependent diabetes mellitus before kidney and/or pancreas transplant
22. Use of dobutamine echocardiography for cardiac risk stratification of patients with chronic renal failure
23. Enhancement of left ventricular cavity opacification by harmonic imaging after venous injection of albunex
24. Opacification and border delineation improvement in patients with suboptimal endocardial border visualization
25. The "hurricane sign": Evidence of patient motion artifact on cardiac single-photon emission computed tomographic imaging
26. Serial thallium-201 myocardial imaging after dipyridamole infusion: Diagnostic utility in detecting coronary stenosis and relationship to regional wall motion
27. Dobutamine thallium myocardial perfusion tomography
28. Assessment of myocardial perfusion by single-photon images
29. Non-invasive risk stratification of diabetic and non-diabetic uremic renal allograft candidates using dipyridamole thallium 201 imaging and radionucleotide ventriculography
30. Prognostic value of intravenous dipyridamole thallium imaging in patients with diabetes mellitus considered for renal transplantation
31. Diagnostic value of myocardial thallium stress scintigraphy in the selection of CAD in patients undergoing chronic hemodialysis
32. Predictive value of thallium 201 dipyridamole myocardial stress scintigraphy in chronic hemodialysis patients and transplant recipients
33. Dipyridamole thallium 201 perfusion imaging for the study of ischemic heart disease in hemodialysis disease patients
34. Diagnostic accuracy and prognostic value of combined dipyridamole-exercise thallium imaging in hemodialysis patient
35. Usefulness of two-dimensional echocardiography during low-level exercise testing early after uncomplicated acute myocardial infarction
36. Detection of coronary artery disease with exercise two-dimensional echocardiography: Description of a clinically applicable method and comparison with radionuclide ventriculography
37. Two-dimensional echocardiographic evaluation of exercise-induced left and right ventricular asynergy: Correlation with thallium scanning
38. Exercise cross-sectional echocardiographic diagnosis of coronary artery disease
39. Exercise echocardiography
40. Dobutamine stress echocardiography for the detection of significant coronary artery disease in renal transplant candidates
41. Comparative value of dobutamine stress echocardiography versus dipyridamole-cardiolite in preoperative cardiac risk assessment of kidney transplant candidates
42. Diagnostic and prognostic implications of left ventricular cavity obliteration response to dobutamine echocardiography
43. Left bundle branch block and coronary artery disease: Accuracy of dipyridamole thallium-201 single-photon emission computed tomography in patients with exercise anteroseptal perfusion defects
44. Stress echocardiography
45. Why nuclear cardiologists and stress echocardiographers need to cooperate
46. Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis
47. Ankle-arm blood pressure index as a marker for atherosclerotic vascular diseases in hemodialysis patients
48. Evaluation of C-reactive protein, an inflammatory marker, and infectious serology as risk factors for coronary artery disease and myocardial infarction
49. Urinary albumin and insulin as predictors of coronary artery disease: An angiographic study
50. Angiographic progressions of coronary artery disease and the development of myocardial infarction
51. Can coronary angiography predict the site of a subsequent myocardial infarction in patients with mild-to-moderate coronary artery disease?
52. Does visual interpretation of the coronary arteriogram predict the physiologic importance of a coronary artery stenosis?
53. Coronary atherosclerosis is frequently present at angiographically normal sites: Evidence from intravascular ultrasound in man
54. Hypertension due to renal parenchymal disease
55. Hypertension in chronic renal disease
56. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients
57. Multifactorial actions of beta-adrenergic blocking drugs in ischemic heart disease: Current concepts
58. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: Results of the HOPE study and MICRO-HOPE substudy
59. Diagnosis and management of coronary artery disease in patients with end-stage renal disease on hemodialysis
60. Effect of amlodipine on morbidity and mortality in severe chronic heart failure
61. Choice of ESRD treatment strategy according to cardiac status
62. Normalization of lipoprotein lipase and hepatic lipase by gemfibrozil results in correction of lipoprotein abnormalities in chronic renal failure
63. Lipoprotein (a) in renal disease
64. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
65. High density lipoprotein (HDL) particle composition in patients with end stage renal failure (ESRF) on chronic dialysis
66. Moderate doses of aspirin and risk of bleeding in renal failure
67. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease
68. The effects of normal as compared with low hematocrit values in patients with cardiac disease who are receiving hemodialysis and epoetin
69. A prospective randomized European multicentre study of medium-long run mortality and morbidity comparing acetate-free biofiltration and bicarbonate dialysis
70. Mortality and results after cardiac surgery in patients with end-stage renal disease
71. Coronary artery bypass operation in dialysis patients
72. Complications and long-term outcome after percutaneous coronary angioplasty in chronic hemodialysis patients
73. Short and long-term outcome of percutaneous transluminal coronary angioplasty in chronic dialysis patients
74. Angioplasty and stenting in patients with renal disease
75. Coronary revascularization in insulin-dependent diabetic patients with chronic renal failure